Take a look at this article. It looks like this companies share price shot up after a good phase two trial data for NASH. Would this even be possible for Cytodyn if they had good results for the 700mg dosage and announced a partnership?? Curious what others think.

https://seekingalpha.com/article/4406410-madr...ble-to-win